Bayer buys into microreactor technology
Bayer has boosted its presence in the developing microtechnology market with the acquisition of Ehrfeld Mikrotechnik, a specialist in the manufacture of tiny reactors for chemical processes.
Archives for October 3, 2004
EU unveils incentives to develop drugs for children
The European Commission has published details of a new proposed regulation aimed at stimulating research into drugs for use in diseases affecting children.
Cottonseed compound could help in prostate cancer
A drug derived from a natural source - the cottonseed rape plant - could find a new application as a cancer drug after failing to prove itself as a male contraceptive.
Fertin launches Chlorhexidine gum in Singapore
Medicated chewing gum company Fertin has launched its Chlorhexidine therapeutic chewing gum in Singapore, the second chewing gum brand approved since the country's relaxation of its chewing gum ban.
Potential drug discovery for leishmaniasis
Scientists have discovered the antimonial drugs used to treat Leishmaniasis focus on the same drug targets as those drugs used to treat sleeping sickness and Chagas disease, raising the possibility of a multi-functional drug that will cure all three...
Bioprogress' bitter pill to SWALLOW for Stanelco
In a dispute with Stanelco Fibre Optics, Bioprogress Technology has been awarded outright ownership of a master patent giving it exclusive rights to the process of making capsules from non-gelatine materials by means of radio frequency (RF).
Transgenic animal model company raises €4m
France's genOway, the company behind the first-ever cloning of a laboratory rat last year, has reported a double whammy of good news, raising €4 million in funding and forging an alliance with the world's number one drugs company.
Tesco begins massive RFID rollout
UK supermarket chain Tesco has begun rolling out an RFID network to track shipments from its central distribution centre to all 98 of its Tesco Extra superstores, with completion set for Christmas this year.
Profit forecast goes up for Chr Hansen
Leading colours supplier Chr Hansen raises the end of year outlook as natural colours spear growth in the final quarter.
VEGF contributes to asthma development
Scientists at Yale University in the US have discovered the vascular endothelial growth factor (VEGF) plays an important role in the development of the disease and raises the possibility of new asthma drugs that block VEGF receptors and signalling...
Drugs in wastewater: what consequences?
What happens to medicines after their work is done, and they end up in the wastewater stream? This remains a big unanswered question that needs to be answered to gauge the impact of drugs on the environment, according to presentations at the American...
Pall filter 'a leap forward' in bioprocessing
Filtration separation specialist Pall has introduced a new filter technology that improves the effectiveness of bioburden reduction in pharmaceutical production and cuts costs.